CEO: Jeffrey W. Albers

Sector: Health Technology
Industry:Biotechnology

Exchange: NASDAQ

Country: US

Description: Blueprint Medicines Corp. is a precision therapy company. It focuses on medicines to improve the lives of patients with genomically defined cancers, rare diseases and cancer immunotherapy. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy on October 14, 2008 and is headquartered in Cambridge, MA.


Key numbers

Market Capitalization:3996512500
Shares Outstanding: 54190000
Float: 53032664
Next Earning Date:2020-11-04
TTm EPS: -7.4228
TTm Dividend Rate:
200 days moving average:69.69
50 days moving average: 74.04
One day percent Change: -0.96



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,